That's a good question. Yeah, definitely. The FDA is the biggest concern of all the e-cig makers right now. SFIO has said it is trying to make FDA compliance its number 1 concern. See here for their explanation:
The idea is that since their product is the only one of all the e-cigs that releases no smoke or vapor into the ambient air, that they would be the last company the FDA would scrutinize.
But as far as the CBIS JV, that hasn't materialized into anything yet. CBIS seems to be struggling to stay afloat at the moment, so I doubt SFIO would actually get involved in a cannabis e-cig product anytime soon. If they did, you better believe they'd do it under strict limitations, in medical states only, and completely separate from their nicotine product.
I think someone posted information about CBIS doing a possible R/S on this board a bit ago. Its actually a share dividend that they have planned, and all signs point to it being legit. They've made several revisions to their Pre 14C with the SEC, and the final version outlines an increase in A/S shares in order to support the two new stock classes with a 10:1 dividend:
Their stated intention for the dividend is make the development of their cannabis-based pharma an easier, more successful transition. I've never been involved in such a dividend before, so I really can't say whether its going to work or not. If anyone here has experience in this area, I would love to hear your opinion on this 14C...
...greed leads to angry selling which leads to regret which leads to suffering...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.